Trevor Hallam, Chief Scientific Officer at SUTRO BIOPHARMA, INC. (STRO), sold 4,621 shares at $25.68 ($119K) on 2021-01-26, disclosed to the SEC on 2021-01-27.
Open-market sale of $119k STRO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.68 | 2,228 | $57K | 48.2% |
| 2 | $25.68 | 2,228 | $57K | 48.2% |
| 3 | $26.10 | 165 | $4K | 3.6% |
| Total | $25.69 avg | 4,621 | $119K | 100% |
| Filing → |
| STRO | SELL | 2020-11-06 | $251K | — | Filing → |
| STRO | SELL | 2020-09-28 | $10K | — | Filing → |
| STRO | SELL | 2020-08-27 | $9K | — | Filing → |